Amneal Pharmaceuticals | 8-K: Current report
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer BOYER ANDREW S
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shah Nikita
Amneal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amneal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amneal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amneal Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Amneal Pharmaceuticals | 8-K: Current report
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Autor Deborah M.
Amneal Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Alva Emily Peterson
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Autor Deborah M.
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director MEISTER PAUL M
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Nark Ted C
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BUCHI J KEVIN
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director George Jeffrey P.
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kiely John
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Yanai Shlomo
Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Patel Gautam
Amneal Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tushar Patel(17.4%)
No Data
No Data